Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
Sarah J. Shepherd,Claude C. Warzecha,Sagar Yadavali,Rakan El-Mayta,Mohamad-Gabriel Alameh,Lili Wang,Drew Weissman,James M. Wilson,David Issadore,Michael J. Mitchell
DOI: https://doi.org/10.1021/acs.nanolett.1c01353
IF: 10.8
2021-06-30
Nano Letters
Abstract:A major challenge to advance lipid nanoparticles (LNPs) for RNA therapeutics is the development of formulations that can be produced reliably across the various scales of drug development. Microfluidics can generate LNPs with precisely defined properties, but have been limited by challenges in scaling throughput. To address this challenge, we present a scalable, parallelized microfluidic device (PMD) that incorporates an array of 128 mixing channels that operate simultaneously. The PMD achieves a >100× production rate compared to single microfluidic channels, without sacrificing desirable LNP physical properties and potency typical of microfluidic-generated LNPs. In mice, we show superior delivery of LNPs encapsulating either Factor VII siRNA or luciferase-encoding mRNA generated using a PMD compared to conventional mixing, with a 4-fold increase in hepatic gene silencing and 5-fold increase in luciferase expression, respectively. These results suggest that this PMD can generate scalable and reproducible LNP formulations needed for emerging clinical applications, including RNA therapeutics and vaccines.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.1c01353?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.1c01353</a>.Materials and methods for device design, device fabrication, experimental setup, mixing characterization, lipid nanoparticle (LNP) formulation and characterization, siRNA delivery to HeLa cells <i>in vitro</i>, <i>in vivo</i> LNP studies, statistical analysis; PMD design and validation of uniform fabrication; characterization of single stranded DNA LNPs formulated by the single row PMD; characterization of luciferase siRNA LNPs and transfection <i>in vitro</i>; characterization of Factor VII siRNA LNPs and luciferase mRNA LNPs; mouse liver histopathology; liver toxicity assays (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.1c01353/suppl_file/nl1c01353_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology